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mtDNAIn this work we have investigated the effect of a pathogenic mitochondrial DNA mutation found in human
colon cells, at a functional-molecular level. The mutation results in the amino-acid substitution Tyr19His in
subunit I of the human CytcO and it is associated with respiratory deﬁciency. It was introduced into Rho-
dobacter sphaeroides, which carries a cytochrome c oxidase (cytochrome aa3) that serves as a model of the
mitochondrial counterpart. The residue is situated in the middle of a pathway that is used to transfer sub-
strate protons as well as protons that are pumped across the membrane. The Tyr33His (equivalent residue in
the bacterial CytcO) structural variant of the enzyme was puriﬁed and its function was investigated. The
results show that in the structurally altered CytcO the activity decreased due to slowed proton transfer;
proton transfer from an internal proton donor, the highly-conserved Glu286, to the catalytic site was slowed
by a factor of ∼5, while reprotonation of the Glu from solution was slowed by a factor of ∼40. In addition, in
the structural variant proton pumping was completely impaired. These results are explained in terms of
introduction of a barrier for proton transfer through the D pathway and changes in the coordination of water
molecules surrounding the Glu286 residue. The study offers an explanation, at the molecular level, to the link
between a speciﬁc amino-acid substitution and a pathogenic phenotype identiﬁed in human colon cells.O with a two-electron reduced
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Cellular respiration in aerobic organisms involves the transfer of
electrons, coupled to transmembrane proton translocation, through
the respiratory chain. This process takes place in the inner mito-
chondrial membrane of eukaryotes or in the inner cell membrane of
prokaryotes. The ﬁnal electron acceptor is molecular oxygen, which is
reduced to water at the catalytic site of cytochrome c oxidase (CytcO).
Thirteen of the polypeptides of the respiratory chain complexes are
encoded by the mitochondrial DNA (mtDNA), including subunits I–III
of CytcO. Mutations in the mtDNA have for a long time been known
to be linked to various disease states. Typically, mtDNA mutations are
recognized as causes of primary, mitochondrial diseases such as mito-
chondrial encephalomyopathy, lactic acidosis and stroke-like epi-
sodes (MELAS), myoclonic epilepsy with ragged red ﬁbers (MERRF)and Kearns–Sayre syndrome (KSS) due to the mutations accumulat-
ing to high levels in muscle and CNS tissues (see [1,2] for review).
Recent evidence suggest that acquired mtDNA mutations may play a
role in the aetiology of various neurodegenerative disorders [3] [4]
and cancers [5–10]. Furthermore, somatic mtDNAmutations are likely
to appear during the process of normal ageing [2]. Although the list of
mtDNA mutations linked to various diseases is constantly growing,
the consequences of the mutations at a molecular level are rarely
known.
In this work, we have investigated the effects of a pathogenic
mtDNA mutation found in mtDNA encoded subunit I of CytcO. Pye
et al. identiﬁed the mutation in respiratory-deﬁcient transmitochon-
drial cybrid clones isolated from normal colonic crypt cells [11].
Upon sequencing the DNA, a single base substitution, m.5958 T>C
(amino-acid substitution Tyr19His in subunit I, human CytcO amino-
acid residue numbering) was detected. The cell line harboring the
Tyr19His mutation showed a decrease in CytcO activity and a per-
turbed complex assembly compared to the controls [11].
To investigate the functional properties of the Tyr19His structural
alteration, we introduced it into the CytcO (cytochrome aa3) of Rho-
dobacter sphaeroides. This CytcO is composed of four subunits [12,13]
(Fig. 1) of which subunits I–III (the catalytic core) are nearly identical
(sequence and structure) to those of the mammalian CytcO [14]
(subunit IV of the bacterial CytcO is composed of one transmembrane
Fig. 1. Overall structure of R. sphaeroides CytcO (small picture) and subunit I (large picture). Subunit I is shown in gray, subunit II in red, subunit III in pink and subunit IV in yellow.
The gray square illustrates the approximate position of the plasma membrane. The D pathway stretches from Asp132, via protonatable amino-acid residues and water molecules, to
Glu286. The hemes and cupper ions are shown in green and orange, respectively.
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of the mitochondrial counterpart [15]. In earlier studies, CytcOs from
P. denitriﬁcans, R. sphaeroides and yeast have been used to investigate
the effect of other disease-related mutations on the function of CytcO
[16–21].
As indicated above, CytcO catalyzes reduction of O2 to H2O:
O2 þ 4Hþ þ 4e−→2H2O:
The protons are taken up from the more negative (n) side of the
membrane, while the electrons are donated at the positive (p) side,
which results in a transmembrane charge separation conserving part
of the free energy available from the O2-reduction reaction. Further-
more, for each electron transferred to O2 one additional proton is
taken up from the n-side and released to the p-side (i.e. pumped
across the membrane). In the bacterial CytcO, two proton pathways
lead from the n-side solution towards the catalytic site; the D- and K
pathways, named after conserved residues within these pathways.
For each turnover, two of the protons required for O2 reduction are
taken up through the K pathway while the remaining six protons are
taken up through the D pathway. In other words, the latter pathway is
used for transfer of all four protons that are pumped and the remain-
ing two protons used for O2 reduction. The D pathway consists of ∼10
water molecules, which connect a highly-conserved Asp (132 in the
R. sphaeroides CytcO) with a Glu286 (Fig. 1). The latter residue is the
branching site within the D pathway from which protons are trans-
ferred either to the catalytic site or to an acceptor for pumped protons.
The order of electron and proton-transfer events and the kinetics
of these reactions are essentially identical in the R. sphaeroides and
mitochondrial oxidases, and the apparent pKas of the internal proton
donor/acceptor Glu286 are very similar (∼9). These results frommechanistic studies further support the assumption that the bacterial
oxidase is an adequate model of the mitochondrial counterpart. For
recent reviews on the structure and function of CytcO, see [22–30].
Tyr19 is a highly-conserved amino-acid residue corresponding to
Tyr33 in the R. sphaeroides CytcO. It is situated within the D pathway
between residues Asp132 and Glu286 (see Fig. 1) and it is hydrogen-
bonded to one of the water molecules within the pathway. Results
from earlier studies have shown that mutation of residues within the
D pathway inﬂuence rates of proton transfer through the pathway
and, in some cases, also proton pumping is impaired (for review, see
[24]). In the present study we isolated the Tyr33His structural variant
of CytcO from R. sphaeroides and investigated the effects of the muta-
tion. The results show that the mutant CytcO displayed ∼38% activity
(O2 consumption) of that of the wild-type CytcO and that activity
was not linked to proton pumping. Furthermore, we also used time-
resolved absorption spectroscopy to investigate speciﬁc electron and
proton-transfer reactions during reaction of CytcO with O2 in the
Tyr33His mutant CytcO and found that all reaction steps being linked
to proton uptake were slowed.2. Materials and methods
2.1. Site-directed mutagenesis, growth of bacteria and CytcO puriﬁcation
The Tyr33His mutation was constructed using the Quick-Change
mutagenesis kit (Stratagene). The pJS3-SH plasmid [31] was used as
the template for the mutation and the pRK415-1 plasmid [32], con-
taining the genes for subunits I–III of CytcO, was used as expression
plasmid. The expression plasmid with the mutation was transferred
into E. coli S-17-1 cells by electroporation. The plasmidwas transferred
Fig. 2. Absorbance changes as a function of time after ﬂash photolysis of CO from the
fully reduced wild-type and Tyr33His CytcO in the presence of O2. Formation of the PR
state (τ≅30 µs) is seen as an absorbance decrease at 580 nm. It is followed in time by
formation of state F, which is seen as an absorbance increase at 580 nm (τ≅100 µs and
τ≅570 μs with the wild-type and Tyr33His CytcOs, respectively). Formation of the last
intermediate, O, seen as an absorbance decrease at 580 nm, is slower with the Tyr33His
than with the wild-type CytcO (τ≅4 ms and 1.5 ms, respectively). Experimental con-
ditions: 0.1 M Hepes–KOH pH 7.4, 0.1% DDM, 1 mM O2 and ∼1 μM reacting enzyme.
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veriﬁed by sequencing. R. sphaeroides cells were grown aerobically
in shake incubators. After harvesting, membranes were prepared and
the CytcOwas solubilized from the membrane fraction using dodecyl-
β-D-maltoside (DDM). Finally, the His-tagged CytcO was puriﬁed
using Ni2+-NTA afﬁnity chromatography, essentially as described in
[33].
2.2. Steady-state kinetics
The steady-state enzyme kinetics wasmeasured using a Clark-type
oxygen electrode (Hansatech Instruments). Brieﬂy, 0.1 nM puriﬁed
CytcO, 0.05% DDM, 36 µM reduced cytochrome c and 50 mM K+
phosphate buffer at pH 6.5 were added to the oxygraph chamber to a
ﬁnal volume of 1 ml.
2.3. Oxidation of CytcO by oxygen
CytcO at a concentration of 7 µM in 0.1 M Hepes–KOH at pH 7.4,
0.1% DDMwas transferred to an anaerobic cuvette. The atmosphere in
the cuvette was exchanged for N2 after which the CytcO molecules
were reduced using 1 µM phenazine methosulfate and 2 mM ascor-
bate. Complete reduction of CytcO was veriﬁed by analysis of the
absorption spectrum. The N2 atmosphere was then exchanged for CO,
resulting in formation of the CytcO–CO complex where CO is bound to
heme a3. The oxygen-reduction reaction was monitored upon rapidly
mixing fully reduced CO-bound CytcO with an O2-saturated solution
of 0.1 M Hepes–KOH at pH 7.4 and 0.1% DDM in a stopped-ﬂow
apparatus (Applied Photophysics) (mixing ratio 1:5). Approximately
200 ms after mixing, the CO molecule was dissociated from the cata-
lytic site by means of a short laser ﬂash (Quantel, Brilliant B, ∼200 mJ
at 532 nm). This allowed O2 to bind to the reduced catalytic site and
the subsequent reaction was monitored in time by recording the
absorbance changes at single wavelengths.
2.4. Proton-uptake measurements
A solution of 7 μM CytcO in 0.1 M KCl at pH 7.8, 0.1% DDM, sup-
plemented with 40 μM phenol red was prepared. It was transferred
to an anaerobic cuvette and air was exchanged for CO as described
above. The CO-bound CytcO was mixed with an O2-saturated solution
consisting of 0.1 M KCl, 40 μM phenol red at pH 7.8 and 0.1% DDM
after which the CO ligand was dissociated by means of a laser ﬂash
(Flow-ﬂash system from Applied Photophysics). Proton uptake from
solution results in deprotonation of the dye, which is seen as an in-
crease in absorbance at 560 nm.
2.5. Reconstitution of CytcO into liposomes
CytcO-containing lipid vesicles were prepared essentially as de-
scribed in [34]. Brieﬂy, puriﬁed CytcO was diluted to 4 μM in 0.1 M
Hepes–KOH at pH 7.4 and 4% sodium cholate. Soybean lecithin at
a concentration of 40 mg/ml was dissolved in 0.1 M Hepes–KOH at
pH 7.4 and 2% sodium cholate. The lipid solution was sonicated and
mixed with the CytcO solution at a 1:1 ratio. The sodium cholate was
gradually removed using BioBeads SM2 Adsorbent (BioRad Laborato-
ries). Finally, the bufferwas exchanged for a 0.1 MKCl solution at pH7.4
using a PD10 column (GE Health Care). Using the above-mentioned
lipid-to-CytcO ratio, each vesicle typically contains at most one CytcO
molecule and in 75% of the vesicles the CytcOs molecules are oriented
with the cytochrome c-binding site towards the outside solution [34].
2.6. Proton pumping
Liposome-reconstituted CytcO at a concentration of 0.5 μM in
50 μM Hepes–KOH, 45 mM KCl, 44 mM sucrose, 1 mM EDTA and100 μM phenol red at pH 7.6 was mixed at a 1:1 ratio with 16 μM
reduced cytochrome c (in a solution with the same composition as
that in theother syringe) in a stopped-ﬂowspectrophotometer (Applied
Photophysics). Absorbance changes of the pH-sensitive dye were
detected at 554 nm. The potassium ionophore valinomycin was
used to equilibrate the electrical component of the electrochemical
gradient. The proton ionophore carbonyl cyanide 3-chlorophenylhy-
drazone (CCCP) was used to detect the net consumption of protons
during enzyme turnover.
3. Results
The Tyr33His mutation in subunit I of CytcO was expressed in
R. sphaeroides cells and the structural variant (“mutant”) of CytcOwas
puriﬁed using Ni2+-NTA afﬁnity chromatography. The spectral char-
acteristics did not differ from those measured with the wild-type
CytcO, indicating that the metal cofactors and their environments
were intact. In addition, we investigated O2 binding to the reduced
catalytic site and found that the time constant was the same as that
measured with the wild-type CytcO (not shown), also indicating that
the catalytic site was unperturbed in the structural variant of the
CytcO. The multiple turnover activity of the Tyr33His CytcO was mea-
sured at pH 6.5 and found to be 38±6% of that of the wild-type CytcO.
3.1. Reaction of the fully reduced CytcO with O2
The reaction of the fully reduced CytcO with O2 was studied as a
function of time using time-resolved absorption spectroscopy. Fully
reduced (i.e. with four electrons), CO-bound CytcOwasmixedwith an
O2-saturated solution. About 200 ms after mixing, the blocking CO
ligand was dissociated by means of a laser ﬂash, which enabled O2 to
bind at the catalytic site thereby initiating the reaction. Fig. 2 shows
absorbance changes at 580 nm measured with the wild-type and
Tyr33His CytcOs at pH 7.4. Results from earlier studies with the wild-
type R. sphaeroides CytcO have shown that these absorbance changes
reﬂect four distinct transitions ([35,36], for review, see [24,30,37,38]):
(i) Binding of O2 to the reduced CytcO immediately after dissociation
of the CO ligand (τ≅8 µs at 1 mM O2), not seen on the time scale
shown in Fig. 2. (ii) Transfer of an electron from heme a to the
catalytic site forming a state that is denoted PR in which the O-O bond
is broken (τ≅30 µs at pH 7.4). This reaction is seen as a decrease
Fig. 4. The pH dependence of the (a) PR to F and (b) F to O rates during reaction of the
fully reduced wild-type and Tyr33His CytcO with O2. The rates were extracted from
data obtained at 580 nm and 445 nm. Filled and open circles show data for the Tyr33His
and wild-type CytcOs, respectively. The data obtained with the wild-type CytcO are
from [30,39]. Experimental conditions: 0.1 M MES (pH 6.5), 0.1 M Hepes–KOH (pH 7.4
and 8.0), 0.1 M Tris (pH 9.0) and 0.1 M CAPS (pH 10.0), 0.1% DDM, 1 mM O2 and ∼1 μM
reacting enzyme.
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D pathway to the catalytic site forming a state denoted F, fractional
electron transfer from CuA to heme a and proton pumping, all occurr-
ing with a time constant of ∼100 µs at pH 7.4. This step is most clearly
seen as an absorbance increase at 580 nm (Fig. 2). (iv) Transfer of
the last (fourth) electron and a proton through the D pathway to the
catalytic site forming the oxidized CytcO, as well as proton pump-
ing (τ≅1.5 ms at pH 7.4). This last transition is seen as a decrease in
absorbance at 580 nm.
As shown in Fig. 2, the ﬁrst two reactions until formation of the
PR state occurred over the same time scale with the Tyr33His and
wild-type CytcOs. However, those transitions that are linked to proton
uptake (and pumping in the wild-type CytcO) were slowed in the
Tyr33His CytcO; The PR→F reaction was slowed from ∼100 µs with
the wild-type CytcO to ∼600 µs with the Tyr33His enzyme, while the
next, F→O reaction, was slowed from 1.5 ms to 4 ms.
3.2. Dependency of the CytcO oxidation reaction on pH
The rate of the oxygen-reduction reaction was also measured at
a number of different pH values from 6.5 to 10 (Fig. 4a). With the
Tyr33His mutant CytcO the F-formation rate was essentially the
same at all pH values (∼600 µs). This is in contrast to results with the
wild-type CytcO, for which the time constant is essentially constant
(∼100 µs) up to pH ∼9 after which it increases displaying an apparent
pKa of ∼9.4 [39]. The time constant for formation of state O increased
with increasing pH as shown in Fig. 4b, which is qualitatively the same
dependence as that found with the wild-type CytcO, although the
slowing as a result of the mutation is more pronounced at low than at
high pH.
3.3. Proton-uptake measurements
Proton uptake to the catalytic site during oxidation of the reduced
CytcOwasmeasured using the pH-sensitive dye phenol red upon ﬂash
photolysis of the CO ligand after mixing of the CO-bound CytcO with
an O2-saturated buffer-free solution at pH 7.8 (Fig. 3, an increase in
absorbance corresponds to uptake of protons). With the wild-type
CytcO two main kinetic components are typically observed with time
constants corresponding to those of the PR→F and F→O transitions,
i.e. ∼100 µs and ∼1.5 ms [35]. With the Tyr33His CytcO only oneFig. 3. Absorbance changes of the dye phenol red at 560 nm associated with changes in
proton concentration of the bulk solution upon reaction of the fully reduced wild-type
and Tyr33His CytcO with O2. An increase in absorbance indicates alkalinization of the
surrounding solution. The solid lines superimposed on the traces are ﬁts of the data.
With the wild-type enzyme the ﬁt is a sum of two exponentials with time constants of
∼100 μs (PR to F) and ∼1.7 ms (F to O), respectively. With the Tyr33His CytcO, the
absorbance increase was ﬁtted to a single exponential with a time constant of ∼3 ms.
Experimental conditions: 0.1 M KCl, pH∼7.8, 0.1% DDM, 40 μM phenol red, 1 mM O2.component, with a time constant of∼3 ms, was observed i.e. it approx-
imately coincided in time with formation of the O state.
3.4. Proton-pumping activity
Proton pumping was investigated uponmixing a solution of CytcO,
reconstituted in liposomes, with reduced cytochrome c in the pres-
ence of O2. The pH-sensitive dye phenol red was added on the outside
of the vesicles and changes in the dye absorbance were detected
at 554 nm (Fig. 5), which is an isosbestic point for the reduced and
oxidized forms of cytochrome c (yet it is close to the absorbance
maximum for protonation changes of the pH dye). First, the potassium
ionophore valinomycin was added to equilibrate the electrical com-
ponent of the electrochemical gradient formed across the vesicle
membrane. With the wild-type CytcO, there is a decrease in absor-
bance, consistent with acidiﬁcation of the solution outside of the
vesicles. Then, upon addition of the proton ionophore CCCP, protons
equilibrate across the membrane and an increase in the dye absor-
bance is seen, consistent with a net uptake of protons (the “pumped
protons” equilibrate across the membrane and only the net uptake
of substrate protons is observed). Because four protons are consumed
for each turnover, the absorbance increase with CCCP can be used
to calibrate the signals. As seen in Fig. 5, no proton pumping was
detected with the Tyr33His CytcO.
4. Discussion
In this workwe have investigated, at amolecular level, the effect of
the pathogenic Tyr33His mutation in subunit I of CytcO, originally
Fig. 5. Absorbance changes of the dye phenol red at 554 nm associated with changes in
proton concentration uponmixing vesicle-reconstitutedwild-type and Tyr33His CytcOs
with reduced cytochrome c. The potassium ionophore valinomycin was added to equil-
ibrate the electrical component of the electrochemical gradient formed across the
vesicle membrane (lower two traces). With the wild-type CytcO, there is a decrease in
absorbance due to acidiﬁcation of the solution outside the vesicles. With the Tyr33His
CytcO, there is no absorbance decrease, indicating that no protons are released to the
outside of the vesicles. Addition of the proton ionophore CCCP results in proton equili-
bration across the vesicle membrane and an increase in the phenol red absorbance is
seen, consistent with a net uptake of protons. Experimental conditions after mixing:
0.25 μM liposome-reconstituted CytcO, 50 μM Hepes–KOH, pH 7.6, 45 mM KCl, 44 mM
sucrose, 1 mMEDTA, 100 μMphenol red, 8 μMreduced cytochrome c, 1 μMvalinomycin,
2.5 μM CCCP.
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was successfully expressed in R. sphaeroides cells and could be puri-
ﬁed using Ni2+-NTA afﬁnity chromatography. The Tyr33 residue is
found in the D pathway, which is used to transfer protons to the cata-
lytic site during oxygen reduction as well as protons that are pumped
across the membrane (see Fig. 1).
The puriﬁed Tyr33His CytcO showed a number of differences com-
pared to the wild-type enzyme: (i) the steady-state turnover rate (i.e.
oxygen reduction) was decreased to ∼38% of that of the wild-type
CytcO; (ii) the PR→F and F→O rates in the reaction of the reduced
CytcO with O2 were decreased; (iii) no proton uptake to the catalytic
site from solution was observed on the time scale of F formation;
(iv) the proton-pumping activity of the CytcO was abolished.
The lower steady-state activity observed with the Tyr33His CytcO
is consistent with the results of Pye et al. [11], which showed that the
CytcO activity decreased in the transmitochondrial cybrids harboring
the equivalent mutation. Also results from other studies have shown
that mutation of a number of speciﬁc amino-acid residues lining the
D pathway result in a decrease in the steady-state activity of CytcO,
presumably due to slowed proton transfer through the pathway (see
for example [40,41]). Pﬁtzner et al. previously investigated theTyr35Phe
mutation in CytcO from P. denitriﬁcans (corresponds to Tyr33Phe in the
R. sphaeroides CytcO) [40] and found that the mutant displayed lower
steady-state activity compared to the wild-type CytcO. However, the
Tyr35Phe mutation had no effect on proton pumping.
To investigate which speciﬁc reaction steps that were slowed as a
result of the Tyr33His mutation, we investigated the reaction of the
reduced CytcO with O2 as a function of time. In this reaction the initial
bindingofO2 to the reduced catalytic site andsplittingof theO-Obondare
not associatedwith anyprotonuptake fromsolution; these reactions only
involve internal electron transfer fromheme a to heme a3 and an internal
redistribution of protons. Accordingly, the rates of these reactions were
not affected by the Tyr33His mutation and formation of the PR state
occurred over the same time scale as in the wild-type CytcO, which
indicates that themutationdidnot affect the inter-hemeelectron transfer.
The ﬁrst transition that involves proton uptake from solution and
pumping (in the wild-type CytcO) is the PR→F transition [42,43],where formation of the F state requires protonation of a group at the
catalytic site. Also the next transition, F→O, involves proton uptake
from solution and pumping, and all these proton transfers take place
through the D pathway.
In the wild-type CytcO, during the PR→F transition, initially a
proton is transferred from Glu286 to the catalytic site with a time
constant of ∼100 µs and then the residue is rapidly (≪100 µs) repro-
tonated from solution (see Fig. 6a), i.e. the PR→F reaction is linked to
proton uptake from solution with the same rate as that of the PR→F
reaction itself. The reaction is pH dependent titratingwith an apparent
pKa of 9.4, where this pKa reﬂects the protonation state of the Glu286
residue [39]. Observation of an apparent pKa in the pH dependence
of the rate requires that Glu286 is in rapid (≪100 µs) equilibrium
with solution [39]. If this is not the case and the equilibrium occurs
over time scales ≫100 µs, a pH-independent PR→F rate would be
observed. This pH-independent rate would be observed because in
this case the reaction rate is only determined by proton transfer from
Glu286 to the catalytic site [39] and Glu286 is reprotonated after the
internal proton transfer (i.e. proton uptake from solutionwould follow
in time after the PR→F transition itself). In the Tyr33His CytcO the
PR→F rate was approximately the same in the pH range from 6.5 to
10.0 (τ≅600 µs) (Fig. 4a) and there was no proton uptake associated
with formationof state F (Fig. 3). Thus, these results indicate that in the
Tyr33Hismutant CytcO thePR→F transition rate is determined only by
internal proton transfer from Glu286 to the catalytic site (τ≅600 µs).
Observation of the PR→F transition at pH 10.0 indicates that there is
a proton available at Glu286 at this pH, which would indicate that
the pKa of the Glu is elevated as compared to the wild-type CytcO.
Reprotonation of Glu286 occurred over a longer time scale as it coin-
cidedwith the next transition, F→O (Fig. 3). In otherwords, the results
suggest that reprotonation of the Glu286 residue through the D path-
way was slowed by a factor of >30 because proton uptake from
solution was observed only with a time constant of ∼3 ms (pH 7.4)
compared to≪100 µs in the wild-type CytcO (see Fig. 6).
A number of studies with bacterial CytcOs have shown that muta-
tions of residues in the D pathway result in either slowed proton
uptake to the catalytic site or impaired proton pumping, or both
[26,40,44–50] (see also [51–58] for relevant results from theoretical
studies). The residue investigated in the present study is located very
close to a water cluster within the D pathway, located 6–7 Å from
(below) Glu286. This cluster, stabilized by residues Ser200 and Ser201
has been proposed to be important for proton conduction to Glu286
as well as for the proton-pumping function [53,59,60]. Indeed, muta-
tions of residues Ser200 and Ser201 result in lower CytcO activity [40]
and proton transfer from Glu286 is signiﬁcantly slowed, presumably
due to changes in the water structure around the Glu (Lee et al.,
unpublished data). As Tyr33 is located just below these Ser residues,
we speculate that the Tyr33His mutation may also result in altering
the structure of this water cluster and thereby the hydrogen-bonding
pattern around Glu286. The slowed reprotonation of the Glu286
residue in the mutant CytcO is most likely due to introduction of a
barrier around the His33 residue (in the mutant CytcO), which is
located in between the entrance of the D pathway and Glu286.
In the Tyr33His mutant CytcO proton pumping was impaired (see
Fig. 5). As discussed above, uncoupling of proton pumping from O2
reduction has been observed previously upon mutation of other
residues in the D pathways of the P. denitriﬁcans and R. sphaeroides
CytcOs. In some cases, such as the Asp132Asn mutant CytcO, the
mutations result in slowed proton transfer through the D pathway
[41]. In other cases, such as e.g. Asn139Asp or Asn139Thr, the proton-
transfer rate through the D pathway was not affected [45,46]. In other
words, a decrease in (or absence of) the pumping stoichiometry is not
necessarily linked to a decrease in the proton-transfer rate through the
D pathway. On the other hand, even though proton transfer through
the D pathway may be dramatically decreased, the mutant CytcOmay
still pump protons. For example, in the Glu286Ala/Ile112Glu [61] and
Fig. 6.Models showing the rates of proton transfer from Glu286 to the catalytic site and from solution to Glu286 in (a) wild-type and (b) Tyr33His CytcOs. Amino-acid residues of the
D pathway are shown in black and the oxygen atoms of the water molecules lining the pathway are colored red. Hydrogen bonds are shown in green. With the wild-type CytcO a
proton is transferred from Glu286 to the catalytic site upon formation of state F (τ≅100 μs at pH 7.4) and Glu286 is rapidly (τ≪100 μs) reprotonated from solution. In addition, a
proton is pumped across the membrane. With the Tyr33His enzyme, proton transfer from Glu286 to the catalytic site is slowed (τ≅570 μs at pH 7.4) and reprotonation of Glu286
occurs over the same time scale as formation of state O (τ≅4 ms at pH 7.4). No protons are pumped.
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CytcOs the proton-transfer rates at pH 7 were decreased by a factor of
∼50, but these structural variants pumped protons, although with a
lowered stoichiometry. Common to non-pumping structural variants
where the proton-transfer rate is unperturbed and pumping variants
where the rate is slowed is that the apparent pKa of Glu286 is shifted up
or down from the value of 9.4 in the wild-type CytcO [45,46,48]. Such
pKa shifts most likely reﬂect changes in structure around the Glu286
site upon mutation of residues within the D pathway. Indeed, small
alterations around the Glu286 site have been observed in the structure
of the Asn139Asp mutant CytcO [62] and also in the FTIR spectra of
the mutant CytcO [63]. Furthermore, results from theoretical studies
indicate that Glu286 can adopt different conformations with different
proton connectivity to solution or the pumping site and that these
structural rearrangements are important for controlling proton deli-
very to the pump element maintaining a high pumping stoichiometry
[55]. Changes in the equilibrium constant between the different posi-
tions of the Glu286 residue are expected to result in proton leaks (slip
of the pump) decreasing the pumping stoichiometry [55]. In a recent
study, Qin et al. found that redox-dependent changes in water struc-
ture around Glu286 are likely to modulate proton transfer from the
residue to the catalytic site and the acceptor for pumped protons. We
speculate that in the case of the Tyr33His mutant CytcO proton pump-
ing is impaired due to changes in the water structure around Glu286
(see above). Another possibility is that the absence of proton pumping
is due to slowed proton transfer through the D pathway (c.f. barrier
introduced within the D pathway). However, the latter is less likely as
there are examples ofmutant CytcOs inwhich proton uptake is slowed
but proton pumping is maintained (see above).
5. Conclusions
In this paper, we report results from studies of the Tyr33His muta-
tion in subunit I of R. sphaeroides CytcO. The corresponding mutation
(Tyr19His) originally identiﬁed in normal, human colonic crypt cells
caused a severe mitochondrial respiratory deﬁciency, but the basis forthe deﬁciency at amolecular level has not previously been investigated.
Using puriﬁed CytcO from amodel bacterial systemwehave shown that
in the Tyr33His mutant CytcO the activity is decreased due to
dramatically slowed proton transfer through the D pathway. Further-
more, in the structural variant O2 reduction was not linked to proton
pumping. We speculate that the reason for the uncoupling of the pump
is a change in the structure of water molecules surrounding the highly-
conserved Glu286 residue, which is responsible for proton delivery to
the catalytic site and to the pump element of the CytcO. In conclusion,
the results from this study provide insights into the link betweenminor
protein structural changes caused bymutation of a single residue and a
pathogenic phenotype identiﬁed in human colonic crypt cells.
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